Loteprednol Etabonate 0.5% Eye Drops - TGA Unlicensed Products
HL Pharma has the exclusive distribution rights for numerous products and also specialises in sourcing and supply of products that are unlicensed in Australia.
These products may not have TGA registration or maybe an Australian product with supply issues. They are usually supplied under The Special Access Scheme (SAS) or Authorised Prescriber Scheme (APS). Other pathways to supply include Clinical Trial Supply.
For more product information on Loteprednol Etabonate, 0.5% eye drops, and similar brands such as Lotemax® see below. For further information on sourcing this product or any others, please don't hesitate to contact us.
Loteprednol Etabonate 0.5% Eye Drops
What are Loteprednol Etabonate 0.5% eye drops used for?
Loteprednol Etabonate 0.5% eye drops and brands including Lotemax, are not marketed in Australia.
The ophthalmic suspension Loteprednol etabonate 0.5%, indication is for the treatment of post-operative inflammation following ocular surgery and allergic conjunctivitis.
Supply of Loteprednol Etabonate 0.5% eye drops in Australia
The supply of unlicensed medicine from overseas, for Australia is often done by The Special Access Scheme.
Loteprednol Etabonate 0.5% eye drops and brands including Lotemax®, are supplied under Special Access Scheme (SAS) B.
The SAS A & B system requires the prescriber to notify The Therapeutic Goods Administration (TGA) of the use.
If a prescriber requires many patients to use Loteprednol Etabonate 0.5% eye drops, or other brands such as Lotemax® then they can apply for an Authorised Prescriber approval.